Dr. Shymaa Hatem
Awards
About me
Dr. Shymaa Hatem Abdelazeem was born in 1988, and graduated from College of Pharmacy, Cairo University in 2010. I finished my PhD in 2022 (Faculty of Pharmacy, Ain Shams University). I published 18 research articles in the field of drug delivery in national and international journals. I participated in more than 30 conferences or workshops. I granted a number of awards on national and global levels. I participated in a number of community service programs hosted by the government.
Dr. Shymaa Hatem Abdelazeem, PhD, is a lecturer of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Future University in Egypt.
She was graduated from Faculty of Pharmacy, Cairo University in 2010 with Bachelor's degree in Pharmaceutical Sciences. She took her Master’s degree in Pharmaceutical Sciences in 2018 from Faculty of Pharmacy, Ain Shams University. In 2022, she took her PhD from Faculty of Pharmacy, Ain Shams University in the same field.
She is majoring mainly in nanotechnology and the formulation of nano-cosmeceuticals for treatment of various skin disorders as melasma, psoriasis, alopecia, acne and others and she has several publications in highly prestigious international journals in this regard and several graduation projects with her students focusing on the advancements in that field.
She was awarded with ACDIMA award in its first year for the best research in applied sciences in 2018. Also, she was selected as the best researcher in her field from Faculty of Pharmacy, Future University in Egypt in 2022 in its 1st annual conference. In the same year, she applied for a national patency in order to get her nano-products licenced and authorized for manufacturing in the national market. Moreover, on global level, she was awarded the “Women Noble Academician of the Year Award” among 80,000 potential women by Women Icon powered by Times Women and World Women Council (WWC), USA in 2023.
Due to her stunning outcomes and efforts, she was assigned as an Associate Editor in Future Journal of Pharmaceutical Sciences in 2023. Also, she was appointed as a volunteer reviewer in many international highly prestigious journals related to her field. Additionally, she was nominated by her Faculty as a Quality Assurance representative from her department and member in the committee of the implementation of teaching, learning and evaluation strategies. Moreover, she was honoured to take a diploma from the international leadership centre and was certified as an expert in Arabic women issues. Furthermore, she was selected as one of the Egyptian delegates at the Best Diplomats held in Dubai, UAE, in Bangkok, Thailand, and in Istanbul, Turkey in 2023. Now, her research work focuses on the preparation of nano- formulations for the diagnosis of several brain disorders using radio-labelled compounds in collaboration with the Egyptian Atomic Energy Authority.
Shymaa Hatem has many volunteering activities in several community service programs. She is a potential member in the Egyptian Association of Continuing Medical Education Development in Egypt in 2022 and is responsible for many campaigns encouraging youth to get engaged for the health wellness in Egypt. She is also responsible for the supervision of the scientific material of several courses and conferences that are held under the auspices of the association both nationally and internationally. Also, she volunteers with other local foundations and associations especially those concerning with the development of girls and women in Egypt.
Degrees:
S Hatem, M Nasr, NH Moftah, MH Ragai, AS Geneidi, SA Elkheshen
Expert opinion on drug delivery 15 (10), 2018: 927-935
2- Melatonin vitamin C-based nanovesicles for treatment of androgenic alopecia: design, characterization, and clinical appraisal
S Hatem, M Nasr, NH Moftah, MH Ragai, AS Geneidi, SA Elkheshen
European Journal of Pharmaceutical Sciences 122, 2018: 246-253
3- Recent advances in antioxidant cosmeceutical topical delivery
S Hatem, M Nasr, SA Elkheshen, AS Geneidi
Current Drug Delivery 15 (7), 2018: 953-964
4- Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches
S Hatem, NM El Hoffy, RS Elezaby, M Nasr, AO Kamel, SA Elkheshen
Journal of Drug Delivery Science and Technology 60, 2020: 101984
5- Functionalized chitosan nanoparticles for cutaneous delivery of a skin whitening agent: an approach to clinically augment the therapeutic efficacy for melasma treatment
S Hatem, SA Elkheshen, AO Kamel, M Nasr, NH Moftah, MH Ragai, ...
Drug delivery 29 (1), 2022: 1212-1231
6- Optimization of the colloidal properties of chitosan nanoparticles encapsulating alpha-arbutin
S Hatem, N ElHoffy, R Elezaby, M Nasr, A Osama, S Elkheshen
Archives of Pharmaceutical Sciences Ain Shams University 6 (1), 2022: 17-28
9- Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: A comprehensive in-vitro and in-vivo evaluation
Shymaa Hatem, Maha El-Kayal. European Journal of Pharmaceutical Sciences. 2023
8-Nanotechnology-based strategies overcoming the challenges of retinoblastoma: A comprehensive overview and future perspectives (derived from an under-grad graduation project)
Shymaa Hatem, Donia Mohammed, Nermeen Ezzat. Future Journal of Pharmaceutical Sciences 2024
9-A comparative study between nanostructured lipid carriers and invasomes for the topical delivery of luteolin: Design, Optimization and Pre-clinical investigations for psoriasis treatment
Shymaa Hatem, Maha El-Kayal. Journal of Drug Delivery Science and Technology. 2024.
10-Nano-vesicular systems for melanocytes targeting and melasma treatment: In-vitro characterization, ex-vivo skin retention and clinical appraisal
Shymaa Hatem, Seham A. Elkheshen, Maha Nasr, Amany O. Kamel, Noha H. Moftah, Maha H Ragai, Nada M. El Hoffy, Reham S. Elezaby. International Journal of Pharmaceutics. 2024.
11- Fluidized spanlastics for intranasal brain delivery of lacosamide aiming to control brain seizures: Design, Characterization, Ex-vivo permeation, Radioiodination and In-vivo biodistribution studies
Marwa Eid Sayyed, Shymaa Hatem. Journal of Drug Delivery Science and Technology. 2024.
12-Development of gallic acid loaded composite nanovesicles for the topical treatment of acne: Optimization, Characterization, and Clinical investigation
Shymaa Hatem, Noha H. Moftah, Maha H Ragai, Enas El-Maghawry. Pharmaceutical Development and Technology. 2024
13-Herbal remedies for oral and dental health: a comprehensive review of their multifaceted mechanisms including antimicrobial, anti-inflammatory, and antioxidant pathways
Anwar, M.A., Sayed, G.A., Hal, D.M., Hafeez, M.S., Shatat, A.A.S., Salman, A., Eisa, N.M., Ramadan, A., El-Shiekh, R.A., Hatem, S. and Aly, S.H., 2025. Inflammopharmacology, pp.1-76.
14- Natural remedies proposed for the management of diabetic retinopathy (DR): diabetic complications.
Khidr, E.G., Morad, N.I., Hatem, S., El-Dessouki, A.M., Mohamed, A.F., El-Shiekh, R.A., Hafeez, M.S. and Ghaiad, H.R., 2025. Naunyn-Schmiedeberg's Archives of Pharmacology, pp.1-29.
15-Therapeutic Applications of Ursolic Acid: A comprehensive Review and Utilization of Predictive Tools
Sherien M. Bakry, Riham El-Shiekh, Shymaa Hatem, Asmaa A.Mandour, Ahmed M. El-Dessouki, Abeer Bishr, Heba Elosaily, Ahmed F. Mohamed, Shaza M. Elhusseiny. Future Journal of Pharmaceutical Sciences. 2025
16-Nose to brain delivery of kaempferol loaded magnesomes for the management of Dementia: Radioiodination, invitro and invivo studies
Maha El-Kayal, Marwa Eid Sayyed, Shymaa Hatem. Journal of Pharmaceutical Sciences. 2025
17- Therapeutic Targeting of Ocular Diseases with Emphasis on PI3K/Akt, and OPRL Pathways by Hedera helix L. Saponins: A New Approach for the Treatment of Pseudomonas aeruginosa-induced Bacterial Keratitis
Sherif A. Hamdy1, Shymaa Hatem2*, Heba Elosaily3, Abrar Gomaa Abd-Elfattah Hassan4, Rana Elshimy5,6, Ahmed H. Osman7, Riham A. El-Shiekh1*. Natural Products and Bioprospecting. 2025
18- Neuroprotective Potential of Mangiferin: A Review of Its Effects on Neurological Disorders.
Mohamed Sayed, Aya Mostafa, Shymaa Hatem, Roxane Abdel Gawad, Ghadir Ali. Inflammopharmacology. 2025
19-Lupeol: An Updated Review Utilizing AI-Assisted Predictive Tools for Enhanced Therapeutic Insights into Lupeol’s Potential for Alopecia Management
Aya M. Mustafa; Riham El-Shiekh; Safaa A Faheem; Mariam H. Fawzy; Mohammed E. Abo-El Fetoh; Ahmed F. Mohamed; Shymaa Hatem; Asmaa A. Mandour. Future Journal of Pharmaceutical Sciences. 2025
20- Enhancing Bone Healing via Tissue Engineering: From Conceptual Frameworks to Precision Regenerative Therapies (derived from an under-grad graduation project)
Shymaa Hatem; Hanin Kashef; Aya Gouda; Menatullah Momen; Nagham Mamdouh; Menatalla Walid; Reem Elsheikh. Bulletin of Pharmaceutical Sciences Assiut University. 2025
21-Appraisal of glycerol-based soft vesicular systems for nose to brain delivery of melatonin aiming to manage Parkinson's disease: Synthesis, Characterization, Radioiodination and In-vivo biodistribution investigations
Marwa Eid Sayyed, Shymaa Hatem. Journal of Drug Delivery Sciences and Technology. 2025
22- Therapeutic Potential of Purpurin, a Natural Anthraquinone Dye, in Neuroprotection and Neurological Disorders
Aya M. Mustafa; Ghadir A. Bastawesy; Shymaa Hatem; Roxane Abdel-Gawad Moussa; Dina M. Hal; Mahmoud A. Mansour; Mohamed S. Abd El Hafeez. Inflammopharmacology 2025
23- Biological Modulation and Repair Using Plant-Derived Bioactives: Advancements in Tissue Engineering and Regenerative Medicine. Shymaa Hatem, Riham El-Shiekh, Roxane Abdel Gawad, Eman Bsieso. Future Journal of Pharmaceutical Sciences 2026 (Under Review)